Physician profile
Derek Mullinix
NPI 1689628323
$10,521.18
in general payments reported to CMS, 2019-2025
37 companies · $1,729 in 2025
The $1,729 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,482 · 2020: $1,082 · 2021: $1,155 · 2022: $1,916 · 2023: $1,568 · 2024: $1,589 · 2025: $1,729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,834 · Education: $51.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,834.18 |
| Education | $51.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,272.77 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $1,281.11 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $1,153.76 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $914.29 | 2021-2025 | |
| Amgen INC. | $878.79 | 2019-2025 | Otezla, Repatha, Otezla |
| Lilly USA, LLC | $658.59 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $636.26 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $458.84 | 2019-2025 | Jardiance, Synjardy |
| Pfizer INC. | $387.04 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $303.05 | 2019-2024 | Pneumovax 23, Vaxneuvance, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $275.06 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $180.17 | 2019-2024 | Trulance, Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $153.20 | 2021-2023 | Trintellix |
| Biohaven Pharmaceutical Holding Company LTD. | $134.07 | 2022 | |
| Boston Scientific Corporation | $115.51 | 2024-2025 | Wavewriter Alpha Prime 16 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $85.97 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $74.94 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $62.43 | 2021 | |
| Eisai INC. | $51.05 | 2020-2021 | |
| Amarin Pharma, INC. | $49.86 | 2020-2022 | |
| Phathom Pharmaceuticals, INC. | $45.95 | 2024-2025 | Voquezna |
| Teva Pharmaceuticals USA, INC. | $39.43 | 2019-2020 | |
| Shire North American Group INC | $33.66 | 2019 | |
| Horizon Therapeutics Plc | $33.62 | 2022 | |
| Daiichi Sankyo INC. | $26.59 | 2024 | Injectafer |
| Kowa Pharmaceuticals America, INC. | $26.21 | 2019-2021 | |
| Hologic Sales and Service, LLC | $23.49 | 2022 | |
| Abiomed | $22.17 | 2024 | Impella |
| Edwards Lifesciences Corporation | $21.63 | 2025 | Sapien 3 Ultra Resilia |
| Arbor Pharmaceuticals, INC. | $18.29 | 2020 | |
| Esperion Therapeutics, INC. | $16.82 | 2020 | |
| Genentech USA, INC. | $16.32 | 2020 | |
| Scynexis, INC. | $16.06 | 2022 | |
| Shield Therapeutics INC | $14.85 | 2024 | |
| Astellas Pharma US INC | $13.37 | 2020 | |
| Alexion Pharmaceuticals, INC. | $13.16 | 2020 | |
| Exact Sciences Corporation | $12.80 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Mullinix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.